Drug found effective

PharmaGap Inc.’s latest round of animal testing for its lead cancer drug, PhG-alpha, indicates “statistically significant effectiveness” in treating human PharmaGap-logo.JPGbreast and colon cancer. During testing, mice implanted with cancer tissue and subsequently injected with the drug showed greatly reduced growth of tumours versus mice treated with standard chemotherapy. Ottawa-based PharmaGap says the study indicates that PhG-alpha-1 could be developed into an effective cancer agent. The company continues to analyze data from the study and will release its findings as they become available.

Submit a comment

Please leave your name, which will be used to sign your submission to the SCANsite. Thanks for contributing your thoughts. Come back again. Tony Patterson, Editor & CEO.

© 2006 - 2009 SCAN
INTEGRITY INTELLIGENCE INFORMATION
Site by Citadel Rock
SCAN